resistance

You have access
Acquisition of Letrozole Resistance Through Activation of the p38/MAPK Signaling Cascade
RASHIDRA R. WALKER, KAREN M. GALLEGOS, MELYSSA R. BRATTON, KITANI P. LEMIEUX, KUN ZHANG, GUANGDI WANG, A. MICHAEL DAVIDSON and SYREETA L. TILGHMAN

Anticancer Research February 2021, 41 (2) 583-599; DOI: https://doi.org/10.21873/anticanres.14810
You have access
Extracellular Acidity-mediated Expression of cPLA2γ Confers Resistance in Gastric Cancer Cells
SUNG-CHUL LIM, TAE-BUM LEE, BYUNG-SOO KANG and SONG IY HAN

Anticancer Research January 2021, 41 (1) 211-218; DOI: https://doi.org/10.21873/anticanres.14767
You have access
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives
MICHELE MASSIMINO, STEFANIA STELLA, ELENA TIRRÒ, MARIA STELLA PENNISI, SILVIA RITA VITALE, ADRIANA PUMA, CHIARA ROMANO, SANDRA DI GREGORIO, CRISTINA TOMARCHIO, FRANCESCO DI RAIMONDO and LIVIA MANZELLA

Anticancer Research May 2020, 40 (5) 2457-2465; DOI: https://doi.org/10.21873/anticanres.14215
You have access
A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib
JUN YAMAMOTO, TAKUYA MURATA, YOSHIHIKO TASHIRO, TAKASHI HIGUCHI, NORIHIKO SUGISAWA, HIROTO NISHINO, SACHIKO INUBUSHI, YU SUN, HYEIN LIM, KENTARO MIYAKE, ATSUSHI HONGO, TSUNEHISA NOMURA, WATARU SAITOH, TAKUYA MORIYA, HIROKAZU TANINO, CHIHIRO HOZUMI, MICHAEL BOUVET, SHREE RAM SINGH, ITARU ENDO and ROBERT M. HOFFMAN

Anticancer Research May 2020, 40 (5) 2509-2514; DOI: https://doi.org/10.21873/anticanres.14221
You have access
Human Glioma Cells Acquire Temozolomide Resistance After Repeated Drug Exposure Via DNA Mismatch Repair Dysfunction
KEI YAMASHIRO, KAZUTAKA NAKAO, SHIGEO OHBA and YUICHI HIROSE

Anticancer Research March 2020, 40 (3) 1315-1323; DOI: https://doi.org/10.21873/anticanres.14073
You have access
Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model
HIROMICHI OSHIRO, YASUNORI TOME, TASUKU KIYUNA, SANG NAM YOON, THINZAR M. LWIN, QINGHONG HAN, YUYING TAN, KENTARO MIYAKE, TAKASHI HIGUCHI, NORIHIKO SUGISAWA, YUKI KATSUYA, JUN HO PARK, ZHIYING ZANG, SAHAR RAZMJOOEI, MICHAEL BOUVET, BRYAN CLARY, SHREE RAM SINGH, FUMINORI KANAYA, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research September 2019, 39 (9) 4667-4671; DOI: https://doi.org/10.21873/anticanres.13648
You have access
The Effects of Eribulin on Breast Cancer Microenvironment Identified Using Eribulin-resistant Breast Cancer Cell Lines
WATARU GOTO, SHINICHIRO KASHIWAGI, YUKA ASANO, KOJI TAKADA, KATSUYUKI TAKAHASHI, HISAKAZU FUJITA, TSUTOMU TAKASHIMA, MASATSUNE SHIBUTANI, RYOSUKE AMANO, SHUHEI TOMITA, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research August 2019, 39 (8) 4031-4041; DOI: https://doi.org/10.21873/anticanres.13559
You have access
Targeted Therapies for Pancreatic Cancer and Hurdles Ahead
MINELA ASLAN, REZA SHAHBAZI, KEZBAN ULUBAYRAM and BULENT OZPOLAT

Anticancer Research December 2018, 38 (12) 6591-6606; DOI: https://doi.org/10.21873/anticanres.13026
You have access
Chronic Sulforaphane Application Does Not Induce Resistance in Renal Cell Carcinoma Cells
JOCHEN RUTZ, EVA JUENGEL, STEPHANIE EULER, SEBASTIAN MAXEINER, SAIRA JUSTIN, FREDERIK ROOS, FELIX K.-H. CHUN and ROMAN A. BLAHETA

Anticancer Research November 2018, 38 (11) 6201-6207; DOI: https://doi.org/10.21873/anticanres.12974
You have access
Inhibition of Survivin by Adenovirus Vector Enhanced Paclitaxel-induced Apoptosis in Breast Cancer Cells
TOSHIHIRO TANAKA and HIROAKI UCHIDA

Anticancer Research July 2018, 38 (7) 4281-4288; DOI: https://doi.org/10.21873/anticanres.12725

Main menu

User menu

Search

resistance

Pages